Seres Banks Serious Cash To Drive Microbiome Therapy To Market

Nestlé Health Science Bags US Rights To SER-109 for CDI

Race
Rivals lining up in race for first microbiome therapy approval • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category